Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Read

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Infection and Immunity|July 24, 2004
Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse modelRosemarie B Alcantara, Richard D A Read, Michelle Wright Valderas, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibodyA Mayer, K A Chester, J Bhatia, et al.
International Journal of Cancer|March 4, 2000
Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion proteinJ Bhatia, S K Sharma, K A Chester, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Infection and Immunity|July 24, 2004
Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse modelRosemarie B Alcantara, Richard D A Read, Michelle Wright Valderas, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: preparation of a genetically engineered anti-CEA single chain Fv antibodyA Mayer, K A Chester, J Bhatia, et al.
International Journal of Cancer|March 4, 2000
Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion proteinJ Bhatia, S K Sharma, K A Chester, et al.
Pageof 2